Light Therapy Intervention in Individuals With Parkinson's Disease

Part of paid clinical trials in Newark, Delaware.

Sponsor
University of Delaware
Study ID
NCT06916260
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Red Light (PDT) — DEVICE
    The intervention is a non invasive and safe practice. By delivering low level wavelength red light to the front part of the head, it can increase blood flow in the area treated and improve functioning of the associated regions, potentially improving symptoms.
  • Placebo — DEVICE
    The intervention is a non invasive and safe practice. Participants will be wearing a helmet that delivered low level light therapy to the brain, and use it for the same amount of time as the treatment group. These participants will however, not receive the actual light and receive a placebo, so the helmet will be off. This is done to control of any potential positive effects of the therapy.

Study Details

The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invasive technique that deliverers low level wavelength light to the front part of the head for 12 minutes. for this study the therapy will be done 3 times a week for 6 weeks. To measure the potential effects on the therapy in Parkinson symptoms, we will do a set of cognitive and motor test before and after the intervention to measure any changes as well as control for any potential markers such as age, sex, disease level, medication and exercise.

Key Dates

Start date
Apr 4, 2025
Status verified
Feb 2025
Primary completion
Jan 29, 2026
Completion
Jul 30, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Active Comparator: Light therapy grpup
  • Sham Comparator: placebo light therapy

Primary Outcome Measure

cognitive symptom improvement [ Time Frame: Done immediately before (pre test) and after (post test) intervention lasting about 1 hour. The intervention lasts about 6 weeks, so in between the pre and post tests there will be about a 6 week period. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Delaware STAR TowerNewarkDelaware19711
Sara Penuela, PhD Student
[email protected]
973-974-0120
John Jeka, PdD
[email protected]
sara Penuela, PhD student (SUB_INVESTIGATOR)
John Jeka, PhD (PRINCIPAL_INVESTIGATOR)
Roxana Burciu, PhD (PRINCIPAL_INVESTIGATOR)
Thomas Buckley, PhED (PRINCIPAL_INVESTIGATOR)

Find similar trials in Newark, DE

By condition
Parkinson's disease
By specialty
NeurologyBrain disorders
By research site
University of Delaware STAR Tower· Newark, DE

Related Studies